When griseofulvin became available in 1959 a critical evaluation of its use in chronic tinea of the nail was begun. Since then 122 patients have been treated with a standard dose § (0.5 g. t.d.s. for one month followed by 0.5 g. b.d.) for a minimum of six months and 74 for two years. As the trial progressed it became evident that a longer course of treatment was required than that suggested in earlier reports on the efficacy of the drug-namely, Williams et al. (1958) and Blank et al. (1959).
When griseofulvin became available in 1959 a critical evaluation of its use in chronic tinea of the nail was begun. Since then 122 patients have been treated with a standard dose § (0.5 g. t.d.s. for one month followed by 0.5 g. b.d.) for a minimum of six months and 74 for two years. As the trial progressed it became evident that a longer course of treatment was required than that suggested in earlier reports on the efficacy of the drug-namely, Williams et al. (1958) and Blank et al. (1959) .
It was therefore decided to treat for two years and to follow up the patient for a further year without treatment. Those failing to take the drug consistently throughout the lengthy period of treatment were transferred to an " intermittent-dose group."
Methods
At the patient's first visit numerous relevant clinical facts were recorded, and towards the end of the trial the blood and stool porphyrin levels were measured. All the nails of the hands and feet were examined mycologically and clinically, as were the soles, outer toe clefts, thumb crutches, and any other apparently affected site.
For the detailed mycological investigations parings were collected into sterile Petri dishes from all the nails, the clinically normal as well as the dystrophic, and skin scrapings were taken from the soles, webs, thumb crutches, and any other site that seemed to be infected. At least nine pieces of nail from each site were cultured-six in malt extract agar containing 40 ,ug. of chloramphenicol per ml. and 0.5 mg. of cycloheximide per ml. and three in peptone glucose agar containing 40 jig. of chloramphenicol per ml. Three or four small pieces of nail from each site were examined by direct microscopy in 300%' potassium hydroxide (KOH). Skin scrapings were similarly investigated. The Table I . Response to treatment may be judged from two sets of criteria-by the clinical observation of dystrophy, and the mycological evidence of mycelium in KOH preparations or the isolation of dermatophyte fungi. When fungus is observed or is isolated from a dystrophic nail it is irrefutable evidence of infection ; on the other hand the failure to discover fungus in the parings from a particular nail is not necessarily evidence that the whole nail is uninfected. However, where the nail has been repeatedly examined for fungus by two methods over a period of many months the possibility of missing an infection must be small, and in this respect it is noteworthy that during these studies dermatophyte fungi were found in clinically normal nails. Nail 
Onychomycosis-Fungus Unknown
In 26 patients treated for over six months, while no fungus was isolated, a diagnosis of onychomycosis was confirmed when mycelium was observed in KOH preparations. Of these patients 13 were treated for two years-two with the standard dose and 11 with intermittent dosage-and six were followed for a year after treatment. Despite repeated attempts no fungus was isolated from the nails of these patients. The percentage of nails infected according to clinical and mycological criteria during the course of treatment and follow-up periods is given in Table IV . The trial described was terminated in 1964. In October 1966 a questionary was sent to 74 patients who had been treated for two years. They were asked if their finger-nails and toe-nails were better or worse, how many were affected, whether they had any irritation or peeling or trouble with the skin of the hands or feet, and whether or not they had consulted a doctor and received treatment for any skin or nail infection.
Only 27 patients returned their forms correctly completed. Of these nine regarded their toe-nail infections as cured, but six of these were known to have had infected toe-nails when they were last seen. Among 18 patients reporting infected toenails five recorded a greater number of infected nails than when they were last seen. Another four stated that all their toe-nails were infected, as shown at their last visit to the clinic. From the patients' own descriptions of the state of their toenails nine seemed to be unchanged.
Only one patient reported a relapsed finger-nail infection, and he had shown a poor response to treatment throughout the course. Three patients reported peeling skin, four recorded irritation, and four had consulted a doctor.
Toxicity
No patient complained of serious subjective side-effects, but a few reported headaches, which ceased either spontaneously or when the tablets were taken with meals. No change in the red and white blood cell counts was observed in patients under treatment.
Griseofulvin when given to rats in large doses intravenously or intraperitoneally has been reported by Paget and Walpole (1958) to have colchicine-like effects on the seminal epithelium and bone marrow. With high dosage in mice, toxic liver damage occurs (De Matteis and Rimington, 1963) , and prolonged intake of griseofulvin leads to the development of hepatoma in the enlarged liver (Hurst and Paget, 1963) . Blood and stool porphyrin levels were determined in 84 of the patients in the present frial, and the results have been reported by Rimington et al. (1963) . Faecal porphyrins were raised in 21 of 50 patients receiving treatment, and in 51 patients in whom erythrocyte porphyrins were determined normal maximum values were exceeded in 20. However, in four out of six patients with onychomycosis who had not been treated with griseofulvin total faecal porphyrins exceeded the normal, and in two blood coproporphyrin levels were slightly raised. Conventional liver-function tests on 10 patients with raised and 10 with normal porphyrin excretion showed no evidence of abnormality.
In vitro Sensitivity of T. rubrum and T. mentagrophytes to Griseofulvin Griseofulvin stock solutions in 50% acetone were sterilized by Seitz filtration, and serial dilutions were made in Sabouraud's glucose peptone agar. The concentrations employed to determine the minimum inhibitory concentrations for strains of T. rubrum ranged from 0.75 to 4 fug./ml. in 0.25-Mg. steps. The inoculum was taken from a freshly grown colony, which when it had attained a diameter of 2 cm. was scraped from the medium, added to S ml. of sterile distilled water in a tissue grinder, and after grinding transferred to a sterile container. Each of a series of plates containing griseofulvin, together with control plates, were then inoculated with three 0.02-ml. drops of the inoculum in random order. The cultures were incubated at 25°C. and read after 10 days, and the next highest concentration to that on which growth was recorded was taken as the minimum inhibitory concentration. A total of 57 cultures obtained from patients before treatment and 186 from patients treated for a year or more were screened. The group of pretreatment isolates had a mean M.I.C. of 1.93 jtg./ml. (S.D. 0.54), the group from treated patients a mean M.I.C. of 2.17 ug./ml. (S.D. 0.54). Studentis t test showed no significant difference between the means of the two groups at the 0.1 level. It may be concluded that in patients infected with T. rubrum failure to respond to treatment is not due to the fungus becoming resistant to the antibiotic.
The griseofulvin concentrations used to determine the minimum inhibitory concentrations for T. mentagrophytes ranged showed no significant difference between the means of the two groups at the 0.2 level. In patients infected with T. mentagrophytes failure to respond to therapy is not due to the fungus becoming adapted to the antibiotic.
Discussion and Conclusions
In 1961 Ainsworth reported, " More than a hundred papers have been published to show that 1 g. daily of griseofulvin taken orally effectively controls infection in man by diverse dermatophytes in all five continents." This has not been our experience in the study described. Most reports have been a clinician's account of his observations on a small number of patients over a brief period, and, apart from the investigation by Stevenson and Djavahiszwili (1961) , even where a clinical diagnosis was confirmed mycologically no consistent mycological investigations appear to have been undertaken.
Alone in the present study have all the nails been repeatedly examined mycologically at regular intervals during and after treatment whether they were dystrophic or not. Stevenson and Djavahiszwili (1961) , with 0.5 g. of griseofulvin thrice daily, found that 5 out of 14 patients still had T. rubrum-infected toe-nails after 15 months' treatment. The two-year treatment in our trial is the longest one described. Both 1 g. of griseofulvin daily for two years and 1.5 g. daily for 15 months have been inadequate for the elimination of toe-nail infections due to T. rubrum. A small group of patients not shown in the results described gave a better response when treated with 1.5 g of griseofulvin daily, but some patients naturally respond better than others. In the follow-up the mycological evidence described showed relapse in toe-nails infected with T. rubrum before it was apparent to the clinician (Fig. 5) . Among patients Griseofulvin-Davies et al.
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Finger-nail infections showed a better response than toe-nails on both mycological and clinical criteria (Fig. 5) , and there was no evidence of relapse during the follow-up. Among patients completing questionaries only one described a relapsed finger-nail infection, and he had shown little response to treatment. From the mycological evidence of thumb crutch and outer toe web infections due to T. rubrum, the response of smooth-skin infections parallels that of the nails. After two years 95% of the patients had clear thumb crutches, and there is no evidence of relapse during the year without treatment, whereas with outer toe web infections only 53 % of the patients had clear toe webs after two years' treatment, and this fell to 45% during the year without treatment.
In no case could a patient's failure to respond to therapy be ascribed to the fungus becoming insensitive to the drug. The rate of growth of finger-nails was unrelated to therapeutic response, as also was the griseofulvin serum levels attained in a limited number of patients.
Mycological observation on patients with nails infected with T. mentagrophytes showed that some became worse during the course of treatment; this was not observed in patients with T. rubrum infections, and only one patient with a T. rubrum infection was not improved. In patients whose nails were infected with both these fungi the frequency with which T. mentagrophytes was isolated relative to T. rubrum increased during the course of treatment. It may be concluded, therefore, that in nails T. mentagrophytes is less likely to be inhibited by oral griseofulvin than T. rubrum; in-vitro tests showed that T. rubrum has a mean M.I.C. of 2 /ig./ml., whereas that for T. menta-aroPhvtes was 6.25 iig./ml.
The fact that toe-nail and outer toe web infections did not respond as well as finger-nail and thumb crutch infections may be due to a variety of causes. Gentles (1958) and Gentles et al. (1959) have shown that griseofulvin is incorporated in hair, where it presents a barrier to fungal penetration. There seems to be no record of griseofulvin having been recovered from human nails, or of the amounts in finger-nails versus toenails. The moisture content of the skin in the toe webs must, however, be higher than that of the thumb crutch, and the effect of sweat in leaching out griseofulvin from the tissues cannot be overlooked. The warm moist feet present a better ecological niche for fungal colonization than the hands, which tend to be drier and cooler, and this alone may account for early relapse in infections of the feet after the cessation of treatment when fungus has not been completely eradicated by the fungistatic antibiotic.
It has been found (Davies, in preparation) that finger-nail is more slowly hydrolysed by KOH than is toe-nail, and appears to be a more compact tissue into which griseofulvin may be incorporated as a barrier to fungal penetration. The fingers have a better blood supply than the feet, and finger-nails may consequently receive more griseofulvin, though while the fingernails grow more quickly than toe-nails it does not necessarily follow that the concentration of griseofulvin in the tissue is higher. What must be concluded, however, is that insufficient griseofulvin is incorporated in toe-nails with the dosages so far tried. Though the drug has a low toxicity with the dose regimen prescribed in the present study, it has affected blood and stool porphyrin levels. In high dosage it has colchicinelike effects on nuclear division, and any long-term toxic effect must await the test of time. Griseofulvin, however, must remain the treatment of choice for finger-nail infections, especially in women, but should never be prescribed for smooth skin infections, which are resolved with topical treatments, and its use in toe-nail infection is justifiable only when the patient has severe discomfort. Whether dosage with the new finerparticle-sized variant of the drug can be increased sufficiently to cure the chronic toe-nail infection without any deleterious effect remains to be seen.
Summary
Griseofulvin by mouth was used to treat 122 patients with chronic fungal infections of their nails for a minimum of six months; 74 received the drug continuously for two years, and 36 were followed for another year after the cessation of treatment to study relapse. Patients were assessed clinically at sixweek intervals and a detailed mycological investigation of all their nails, thumb crutches, and outer toe webs was undertaken before treatment and at six-monthly intervals thereafter. All patients were prescribed 0.5 g. of griseofulvin t.d.s. for the first month, followed by 0.5 g. b.d.; those failing to take the drug consistently were transferred to an intermittent-dose group.
Treatment was found to be less effective in infections of the toenails and outer toe webs than in those of the finger-nails and thumb crutches, which showed a good response; a significant number of toe-nails and outer toe webs relapsed after treatment was stopped.
The response of patients with infections due to Trichophyton rubrum is described in detail, as they comprised the largest group ; that of patients infected with T. mentagrophytes, mixed infections due to both these fungi and of patients with chronic onychomycosis but from whom no fungus was isolated are only briefly described.
Response to therapy in nails infected with T. mentagrophytes is less favourable than in those infected with T. rubrum, and in nails infected with both these fungi T. mentagrophytes becomes dominant during treatment. In-vitro tests showed that T. mentagrophytes was less sensitive to griseofulvin than T. rubrum. Failure to respond to treatment could not be correlated with the sensitivity of the fungus isolated from any patient, and there was no evidence of the fungi developing an increased resistance to griseofulvin. Observations on toxicity are discussed, and it is concluded that while griseofulvin is the treatment of choice for chronic finger-nail infections it should not be prescribed for smoothskin infections, which are resolved with topical treatments, and its use in toe-nail infections is justifiable only when the patient has severe discomfort.
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